262 related articles for article (PubMed ID: 17541917)
1. [Small-cell lung cancer diagnostic and therapeutic recommendations of Polish Lung Cancer Group].
Krzakowski M; Orłowski T; Roszkowski K; Reinfuss M; Olszewski W; Ramlau R; Kowalski D; Konopa K; Jassem J; Jankowska R; Kozielski J; Wojtukiewicz M; Drosik K; Koralewski P;
Pneumonol Alergol Pol; 2007; 75(1):88-94. PubMed ID: 17541917
[TBL] [Abstract][Full Text] [Related]
2. Concurrent cisplatin-etoposide chemotherapy plus thoracic radiotherapy for limited-stage small cell lung cancer. Japanese Lung Cancer Chemotherapy Group in Japanese Clinical Oncology Group.
Ariyoshi Y; Fukuoka M; Furuse K; Saijo N; Ikegami H; Nishiwaki Y; Tamura T; Shimoyama M; Suemasu K
Jpn J Clin Oncol; 1994 Oct; 24(5):275-81. PubMed ID: 7967106
[TBL] [Abstract][Full Text] [Related]
3. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
[TBL] [Abstract][Full Text] [Related]
4. [Small-cell lung cancer].
Pérez-Gracia JL; López-Picazo JM; Martín-Algarra S; Viteri S; García-Foncillas J; Gúrpide A
Rev Med Univ Navarra; 2007; 51(2):7-13. PubMed ID: 17886708
[TBL] [Abstract][Full Text] [Related]
5. [Small cell lung carcinoma].
Pujol JL; Quantin X; Jacot W; Boher JM; Molinier O; Godard P
Rev Prat; 2003 Apr; 53(7):735-42. PubMed ID: 12879796
[TBL] [Abstract][Full Text] [Related]
6. Alternating chemotherapy with cyclophosphamide, doxorubicin, vincristine and cisplatin, etoposide followed by prophylactic cranial and thoracic irradiation for small cell lung cancer (SCLC): long-term results.
Ardizzoni A; Fusco V; Pennucci C; Baldini E; Orsatti M; Vitale V; Bonavia M; Baracco F; Mereu C; Rosso R
Anticancer Res; 1991; 11(2):681-4. PubMed ID: 1648333
[TBL] [Abstract][Full Text] [Related]
7. A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer.
Yamada K; Saijo N; Kojima A; Ohe Y; Tamura T; Sasaki Y; Eguchi K; Shinkai T; Goya T; Kondou H
Jpn J Clin Oncol; 1991 Feb; 21(1):39-45. PubMed ID: 1648633
[TBL] [Abstract][Full Text] [Related]
8. Management of small-cell lung cancer.
Johnson BE
Clin Chest Med; 1993 Mar; 14(1):173-87. PubMed ID: 8384962
[TBL] [Abstract][Full Text] [Related]
9. [Current perspectives in the management of small cell lung cancer].
Fujita J; Saijo N
Gan No Rinsho; 1985 Jan; 31(1):1-19. PubMed ID: 2984443
[TBL] [Abstract][Full Text] [Related]
10. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
11. Decreased metastasis and improved survival with early thoracic radiotherapy and prophylactic cranial irradiation in combined-modality treatment of limited-stage small cell lung cancer.
Kamath SS; McCarley DL; Zlotecki RA
Radiat Oncol Investig; 1998; 6(5):226-32. PubMed ID: 9822169
[TBL] [Abstract][Full Text] [Related]
12. Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101).
Tsuchiya R; Suzuki K; Ichinose Y; Watanabe Y; Yasumitsu T; Ishizuka N; Kato H
J Thorac Cardiovasc Surg; 2005 May; 129(5):977-83. PubMed ID: 15867769
[TBL] [Abstract][Full Text] [Related]
13. Accelerated induction therapy and resection for poor prognosis stage III non-small cell lung cancer.
Rice TW; Adelstein DJ; Koka A; Tefft M; Kirby TJ; Van Kirk MA; Taylor ME; Olencki TE; Peereboom D; Budd GT
Ann Thorac Surg; 1995 Sep; 60(3):586-91; discussion 591-2. PubMed ID: 7677484
[TBL] [Abstract][Full Text] [Related]
14. Combined modality therapy of lung cancer.
Livingston RB
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
[TBL] [Abstract][Full Text] [Related]
15. Use of high-dose etoposide/ifosfamide/carboplatin/epirubicin and peripheral blood progenitor cell transplantation in limited-disease small cell lung cancer.
Brugger W; Frommhold H; Pressler K; Mertelsmann R; Kanz L
Semin Oncol; 1995 Feb; 22(1 Suppl 2):3-8. PubMed ID: 7531368
[TBL] [Abstract][Full Text] [Related]
16. [The effect of chemo-radiotherapy on the remission and survival in patients with limited stage small cell lung cancer].
Bozóky G; Ruby E; Góhér I; Gábor G; Mohos A; Lengyel M
Orv Hetil; 2005 Jul; 146(27):1433-8. PubMed ID: 16089103
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of adjuvant surgical resection after chemotherapy for limited small cell lung cancer. A University of Toronto Lung Oncology Group study.
Shepherd FA; Ginsberg RJ; Patterson GA; Evans WK; Feld R
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):177-86. PubMed ID: 2536868
[TBL] [Abstract][Full Text] [Related]
18. Synchronous primary lung cancer presenting with small cell carcinoma and non-small cell carcinoma: diagnosis and treatment.
Hiraki A; Ueoka H; Yoshino T; Chikamori K; Onishi K; Kiura K; Bessho A; Mimoto J; Date H; Ando A; Shimizu N; Harada M
Oncol Rep; 1999; 6(1):75-80. PubMed ID: 9864405
[TBL] [Abstract][Full Text] [Related]
19. [Recent issue in the treatment of small-cell lung cancer].
Ueoka H; Hiraki S
Gan To Kagaku Ryoho; 1998 Sep; 25(11):1665-70. PubMed ID: 9757190
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment for limited small-cell lung cancer. The University of Toronto Lung Oncology Group experience.
Shepherd FA; Ginsberg RJ; Feld R; Evans WK; Johansen E
J Thorac Cardiovasc Surg; 1991 Mar; 101(3):385-93. PubMed ID: 1847981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
